RTTNews | Aug 3, 2020 04:04PM EDT

16:04 Monday, August 3, 2020 (RTTNews.com) - Neurocrine Biosciences Inc (NBIX) reported a profit for its second quarter that advanced from the same period last year.

The company's bottom line totaled $79.6 million, or $0.81 per share. This compares with $51.3 million, or $0.54 per share, in last year's second quarter.

Excluding items, Neurocrine Biosciences Inc reported adjusted earnings of $139.1 million or $1.42 per share for the period.

Analysts had expected the company to earn $0.73 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter rose 64.8% to $302.4 million from $183.5 million last year.

Neurocrine Biosciences Inc earnings at a glance:

-Earnings (Q2): $139.1 Mln. vs. $67.2 Mln. last year.-EPS (Q2): $1.42 vs. $0.71 last year.-Analysts Estimate: $0.73-Revenue (Q2): $302.4 Mln vs. $183.5 Mln last year.

Read the original article on RTTNews ( https://www.rttnews.com/3117477/neurocrine-biosciences-inc-q2-adjusted-earnings-beat-estimates.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2020 RTTNews.com All Rights Reserved